Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fydrane versus standard topical mydriatic-anesthetic protocol on ocular surface after cataract surgery
2017-003277-34Phase 4Completed
- Sponsor
- Laboratoires Théa
- Start
- Nov 2017
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Mydrane in cataract (2 arms), sponsored by Laboratoires Théa. Primary endpoint: Change in corneal and conjunctival surface staining. Started Nov 2017; status: completed.
02
Drugs
Mydrane
03
Conditions
cataract
Beyond the preview
Go deeper on 2017-003277-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003277-34.